Useful Immunohistochemical Markers of Tumor Differentiation
Open Access
- 22 December 2009
- journal article
- research article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 38 (1), 131-141
- https://doi.org/10.1177/0192623309356449
Abstract
Immunohistochemistry (IHC) has been somewhat underutilized in the practice of toxicological pathology but can be a valuable tool for the evaluation of rodent neoplasms, both in a diagnostic and an investigational role. Determining an exact tumor type using standard hematoxylin and eosin (H&E) staining of formalin-fixed tissues can be challenging, especially with metastatic and/or poorly differentiated tumors. Successful IHC is dependent on many factors, including species and tissue type, type and duration of fixation, quality fresh or frozen sectioning, and antibody specificity. The initial approach of most tumor diagnosis IHC applications is distinguishing epithelial from mesenchymal differentiation using vimentin and cytokeratin markers, although false-negative and/or false-positive results may occur. Experimentally, IHC can be employed to investigate the earliest changes in transformed tissues, identifying cellular changes not normally visible with H&E. Individual markers for proliferation, apoptosis, and specific tumor proteins can be used to help distinguish hyperplasia from neoplasia and determine specific tumor origin/type. IHC provides a relatively rapid and simple method to better determine the origin of neoplastic tissue or investigate the behavior or progression of a given neoplasm. Several experimental and diagnostic examples will be presented to illustrate the utility of IHC as a supplement to standard staining techniques.Keywords
This publication has 14 references indexed in Scilit:
- Characterization of Uterine Granular Cell Tumors in B6C3F1 Mice: A Histomorphologic, Immunohistochemical, and Ultrastructural StudyVeterinary Pathology, 2008
- Undifferentiated tumor: true identity by immunohistochemistry.Archives Of Pathology & Laboratory Medicine, 2008
- Bmi-1 Cooperates with H-Ras to Transform Human Mammary Epithelial Cells via Dysregulation of Multiple Growth-Regulatory PathwaysCancer Research, 2007
- WNT/β-catenin signaling in liver health and diseaseHepatology, 2007
- Decreased Expression of Bmi1 Is Closely Associated with Cellular Senescence in Small Bile Ducts in Primary Biliary CirrhosisThe American Journal of Pathology, 2006
- Thiol-reactive compounds prevent nonspecific antibody binding in immunohistochemistryLaboratory Investigation, 2006
- Technical Aspects of ImmunohistochemistryVeterinary Pathology, 2005
- Controls for Immunohistochemistry: Is “Brown” Good Enough?Toxicologic Pathology, 2004
- Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinaseProceedings of the National Academy of Sciences of the United States of America, 2003
- The Morphology, Immunohistochemistry, and Incidence of Hematopoietic Neoplasms in Mice and RatsToxicologic Pathology, 1993